The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree in International Journalism from City, University of London.

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

UnitedHealth's high medical costs and lower-than-expected revenue in the fourth quarter underscored persistent challenges at its insurance unit, sending the healthcare conglomerate's shares down about ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

and the EGFR mutation occurs in 10-15% of the cases in the United States, according to data from the American Lung Association. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shinjini Ganguli) ...